查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
新生儿筛检市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按产品类型、技术、测试类型、最终用户和地理位置
市场调查报告书
商品编码
1372496

新生儿筛检市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按产品类型、技术、测试类型、最终用户和地理位置

Newborn Screening Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type, Technology, Test Type, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 226 Pages | 订单完成后即时交付

价格

全球新生儿筛检市场预计将从 2022 年的 12.06 亿美元增至 2030 年的 24.84 亿美元。预计 2022 年至 2030 年该市场将以 9.4% 的复合年增长率成长。

推动市场的关键因素包括先天性疾病负担的增加和新生儿疾病盛行率的增加。然而，世界各地新生儿筛检政策和程序缺乏统一以及假阳性和假阴性结果阻碍了市场的成长。

新生儿筛检市场的市场机会

随着人们对疾病遗传原因的认识不断加深以及医疗保健技术的进步，对新生儿进行全面基因筛检的需求正在增加。因此，新生儿筛检市场的公司正在开发创新、经济高效的筛检解决方案。美国 FDA 于 2017 年批准 Kymriah 基因疗法用于患有特殊类型急性淋巴细胞白血病的儿科患者。在这个治疗过程中，编码嵌合抗原受体的新基因被插入患者的 T 细胞中，刺激改变的 T 细胞追击并摧毁白血病细胞。 Yescarta 和 Zynteglo 是大 B 细胞淋巴瘤和 β 地中海贫血的授权基因治疗的另外两个例子。此外，技术的出现赋予了识别出生时疾病遗传倾向的能力，为个人化医疗保健铺平了道路，与精准医疗的更广泛趋势保持一致。

孕期遗传疾病筛检的重点还在于及早发现与妊娠相关的问题。新一代定序有助于新生儿产前筛检，检测所有染色体的非整倍体（如唐氏症和 21 三体性）或部分染色体异常（重复或缺失）的敏感度超过 95%。萤光原位杂交（FISH）用于检测镰状细胞性贫血等单基因疾病；它还有助于有效的植入前遗传学诊断。使用母体血浆进行无细胞胎儿 DNA 等非侵入性操作是基因检测的最新进展。胚胎 DNA 可以根据大小差异与母体 DNA 片段区分开来。使用萤光探针的即时 PCR、鸟枪定序（Solexa 或 Illumina）或大规模标靶平行定序可用于检查与胎儿健康状况相关的 DNA。如果进一步研究这种类型的基因筛检，这将使医生能够透过某些药物疗法（药物遗传学）提供早期分子干预，并在物理和化学上改造细胞、组织和器官。因此，婴儿遗传性疾病筛检方法的进步为整个新生儿筛检市场带来了巨大的潜力。

阻碍新生儿筛检市场的因素

不同国家筛检条件清单的差异导致全球新生儿筛检政策和实践的不统一。有些国家对一系列疾病进行全面筛检，而有些国家则专注于有限的一组疾病。这种差异为开发筛选测试和技术的公司带来了障碍，因为他们需要针对特定市场修改其产品，这限制了规模经济。此外，缺乏标准化协议可能会导致品质控制和资料收集实践不一致。这导致筛检结果不准确，并且难以比较地区之间的资料，使得研究人员和医疗保健提供者难以评估在研究地点实施的筛检计画的有效性。此外，缺乏通用标准使新生儿筛检市场营运公司的监管环境变得复杂，因为他们需要专注于遵守复杂的法规网路以寻求不同国家的批准，这可能既耗时又昂贵。缺乏统一性还会阻碍国际合作和资料共享，限制新生儿筛检研究和技术开发的潜力。因此，新生儿筛检政策和程序缺乏统一限制了新生儿筛检市场的进步。

新生儿筛检市场：细分概述

新生儿筛检市场依产品类型分为试剂、检测试剂盒和仪器。 2022年，试剂和检测试剂盒细分市场将占据更大的市场份额，预计未来几年将以最快的速度成长。新生儿筛检的不同试剂和检测试剂盒分为基于 DNA 的检测、免疫检测和酵素检测。市场上的多家公司开发了一系列专门用于新生儿筛检的试剂和检测试剂盒。首先，Labsystems Diagnostics 推出了一种基于萤光微孔板的检测方法，根据苯丙胺酸含量检测新生儿苯丙胺酸 (PKU)，因为婴儿苯丙胺酸水平升高会导致智力障碍。本公司提供的所有试剂盒均为手动模组化系统或全自动免持系统。

新生儿筛检市场依技术分为串联质谱（TMS）、分子测定、免疫测定和酵素测定、脉搏血氧饱和度筛检技术和其他技术。 2022年，脉搏血氧仪筛检技术领域占据最大的市场份额。此外，免疫分析和酵素分析领域预计在未来几年将增长最快。先天性心臟病（CCHD）是最常见的先天性残疾之一，是一种导管依赖性先天性心臟病。它可能在产前和产后期间被发现，如果在新生儿期或婴儿期未经诊断和治疗，可能会危及生命。脉搏血氧仪筛检用于检测婴儿的危重 CCHD。这是一种无痛、非侵入且经济有效的婴儿筛检方法。脉搏血氧仪筛检确定血液中氧饱和的血红素百分比。

新生儿筛检市场依测试类型分为干血斑测试、听力筛检测试、危重先天性心臟病测试和其他测试。 2022年，血斑检测领域占据最大的市场份额。预计同一细分市场的新生儿筛检市场在 2022 年至 2030 年期间将以显着的复合年增长率成长。

新生儿筛检市场按最终用户划分为医院、诊所和诊断实验室。 2022年，医院和诊所细分市场占有更大的市场份额。然而，医院和诊所领域预计在 2022 年至 2030 年期间将以复合年增长率成长。医疗保健提供者在医院的房间或新生儿/托儿所进行新生儿筛检测试。预计未来几年，医院和诊所将在新生儿筛检市场中占据更大份额，因为这些设施接受新生儿筛检的患者人数最多。更好的设施、不同的治疗选择和良好的一站式护理吸引患者前往这些设施接受不同的诊断和治疗程序。

新生儿筛检市场：地理概况

近年来，北美新生儿筛检市场经历了显着成长。随着父母和医疗保健专业人员对早期筛检对于识别和管理先天性疾病重要性的认识不断提高，对新生儿筛检服务的需求显着增加。此外，医疗技术的进步对于增强新生儿筛检能力至关重要——实验室自动化提高了筛检的准确性、速度和成本效益。这使得医疗专业人员能够提供全面的新生儿筛检，涵盖更广泛的遗传和代谢疾病。有利的立法和监管措施也有利于北美的新生儿筛检市场。许多州和省已经实施了强制性新生儿筛检计划，确保所有婴儿在出生后不久就接受筛检。例如，美国每个州都将新生儿筛检作为公共卫生计划；每年，约有 400 万名婴儿根据该计划接受筛检，检查是否患有分娩时不常出现的疾病。德州卫生与公共服务部于 2021 年 6 月开始对新生儿进行脊髓性肌肉萎缩症 (SMA) 筛检。

A few of the major primary and secondary sources referred to while preparing the report on the newborn screening market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (世界卫生组织).

目录

第 1 章：简介

  • Insight Partners 研究报告指南
  • 市场区隔

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：新生儿筛检市场格局

  • 概述
  • PEST分析
    • 全球PEST分析

第 5 章：新生儿筛检市场 - 主要产业动态

  • 主要市场驱动因素
    • 政府为新生儿筛检提供的资金激增
    • 先天性疾病负担不断增加
    • 新生儿疾病盛行率不断增加
  • 主要市场限制
    • 新生儿筛检政策和实践缺乏统一
  • 主要市场机会
    • 新生儿基因筛检
  • 未来的趋势
    • 机器学习和人工智慧在筛检中的整合
  • 影响分析：

第 6 章：新生儿筛检市场 - 全球市场分析

  • 新生儿筛检市场收入，2022 - 2030

第 7 章：全球新生儿筛检市场 - 2030 年收入和预测 - 按产品类型

  • 概述
  • 2022 年及 2030 年新生儿筛检市场收入份额，依产品类型划分 (%)
  • 试剂和检测试剂盒
  • 仪器

第 8 章：全球新生儿筛检市场 - 收入和 2030 年预测 - 按技术分类

  • 概述
  • 2022 年和 2030 年按技术分類的新生儿筛检市场收入份额 (%)
  • 串联质谱 (TMS)
  • 分子检测
  • 免疫测定和酵素测定
  • 脉搏血氧筛检技术
  • 其他技术

第 9 章：全球新生儿筛检市场 - 收入和 2030 年预测 - 按测试类型

  • 概述
  • 2022 年和 2030 年按测试类型分類的新生儿筛检市场收入份额 (%)
  • 干血斑测试
  • 听力筛检测试
  • 严重先天性心臟病 (CCHD) 测试
  • 其他测试类型

第 10 章：全球新生儿筛检市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年和 2030 年新生儿筛检市场收入份额（按最终用户划分）（%）
  • 医院和诊所
  • 诊断实验室

第 11 章：新生儿筛检市场 - 地理分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 12 章：新生儿筛检市场-产业格局

  • 概述
  • 新生儿筛检市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 13 章：公司简介

  • LifeCell International Pvt Ltd
  • Zentech SA
  • Trivitron Healthcare Pvt Ltd
  • PerkinElmer Inc
  • Waters Corp
  • Bio-Rad Laboratories Inc
  • Masimo Corp
  • Natus Medical Inc.
  • Baebies Inc
  • MRC Holland BV
  • Medtronic Plc

第 14 章：附录

  • 关于我们
  • 专业术语
Product Code: TIPHE100001294

The global newborn screening market is expected to reach US$ 2.484 billion in 2030 from US$ 1.206 billion in 2022. The market is estimated to grow with a CAGR of 9.4% from 2022 to 2030.

The key factors driving the market include rising burden of congenital diseases and increasing prevalence of newborn disorders. However, lack of uniformity of newborn screening policies and procedures across the world and false positive and false negative results hinders the market growth.

Market Opportunities of Newborn Screening Market

The demand for comprehensive genetic screening of newborns is rising with the deepening knowledge about the genetic causes of medical conditions and advancements in healthcare technologies. As a result, companies in the newborn screening market are developing innovative, cost-effective screening solutions. The US FDA licensed the Kymriah gene therapy in 2017 for use in pediatric patients with a particular kind of acute lymphoblastic leukemia. During this therapy, a new gene that codes for a chimeric antigen receptor is inserted into the patient's T cells, stimulating the altered T cells to go after and destroy the leukemic cells. Yescarta and Zynteglo are two more examples of authorized gene treatments for large B-cell lymphoma and beta-thalassemia. Further, the emergence of technologies conferring an ability to identify genetic predispositions to diseases at birth pave the way for personalized healthcare, aligning with the broader trend of precision medicine.

Screening for genetic diseases during pregnancy also focuses on the early detection of pregnancy-related problems. Next-generation sequencing aids in the prenatal screening of neonates with a sensitivity of above 95% for detecting aneuploidies (such as Down syndrome and Trisomy 21) or partial chromosomal abnormalities (duplications or deletions) in all chromosomes. Fluorescence in-situ hybridization (FISH) is employed to detect monogenic illnesses such as sickle cell anemia; it also aids in an effective preimplantation genetic diagnosis. Noninvasive procedures such as the cell-free fetal DNA approach using maternal plasma are the recent advancements in genetic tests. The embryonic DNA can be distinguished from maternal DNA pieces based on differences in their sizes. Real-time PCR with fluorescent probes, shotgun sequencing (Solexa or Illumina), or huge targeted parallel sequencing can be used to examine DNA associated with fetal medical conditions. This would allow doctors to provide early molecular interventions with certain pharmacological therapies (pharmacogenetics) and to transform cells, tissues, and organs physically and chemically if this type of genetic screening is further researched. Thus, advancements in methods for screening infants for genetic disorders hold immense potential for the overall newborn screening market.

Factors Hampering Newborn Screening Market

Variations regarding the list of conditions screened for in different countries result in non-uniformity in newborn screening policies and practices worldwide. A few nations screen for a comprehensive range of disorders, while others focus on a limited set. This difference creates barriers for companies developing screening tests and technologies, as they need to modify their products to specific markets, limiting economies of scale. Moreover, the lack of standardized protocols can result in inconsistent quality control and data collection practices. This leads to inaccuracies in screening results and difficulties in comparing data between regions, making it challenging for researchers and healthcare providers to assess the effectiveness of screening programs implemented in localities understudy. Additionally, the absence of universal standards complicates the regulatory landscape for companies operating in the newborn screening market, as they need to focus on complying with a complex web of regulations for seeking approvals in different countries, which can be time-consuming and expensive. The lack of uniformity can also hinder international collaborations and data sharing, limiting the potential of newborn screening research and technology development. Thus, the lack of uniformity in newborn screening policies and procedures limits the progress of the newborn screening market.

Newborn Screening Market: Segmental Overview

The newborn screening market, by product type, is segmented into reagents and assay kits and instruments. In 2022, the reagents and assay kits segment held a larger market share and is expected to grow at the fastest rate in the coming years. Different reagents and assay kits for newborn screening are categorized into DNA-based assays, immunoassays, and enzymatic assays. Various companies in the market have developed a range of reagents and assay kits specifically for neonatal screening. Firstly, Labsystems Diagnostics launched a fluorometric microplate-based assay for detecting phenylketonuria (PKU) in newborns based on phenylalanine content, as increasing the phenylalanine level in the baby can cause intellectual disability. All the reagent kits offered by the Company are manual modular systems or fully automated hands-off systems.

The newborn screening market, by technology, is segmented into tandem mass spectrometry (TMS), molecular assays, immunoassays and enzymatic assays, pulse oximetry screening technology, and other technologies. In 2022, the pulse oximetry screening technology segment held the largest share of the market. Moreover, the immunoassays and enzymatic assays segment is expected to grow fastest during the coming years. Congenital heart disease (CCHD), one of the most common congenital disabilities, is a duct-dependent congenital heart disease. It may be detected during the prenatal and postnatal period, while it can be life-threatening if it goes undiagnosed and untreated in the neonatal period or infancy. Pulse oximetry screening is used to detect critical CCHD in infants. It is a painless, noninvasive, and cost-effective method of screening infants. The pulse oximeter screening determines the percentage of hemoglobin in the blood saturated with oxygen.

The newborn screening market, by test type, is segmented into dry blood spot tests, hearing screen tests, critical congenital heart disease tests, and other tests. In 2022, the blood spot test segment held the largest share of the market. The newborn screening market for the same segment is estimated to grow at a significant CAGR during 2022 -2030.

The newborn screening market, by end-user, is segmented into hospitals, clinics, and diagnostic laboratories. In 2022, the hospitals and clinics segment held a larger market share. However, the hospitals and clinics segment is estimated to grow at a CAGR during 2022-2030. healthcare provider performs newborn screening tests in a room or a newborn/nursery area at hospitals. The hospitals and clinics segment is projected to hold a larger share of the newborn screening market in the coming years as these facilities receive maximum patient footfall for newborn baby screening. Better facilities, and the availability of different treatment options and good nursing care under one roof attract patients toward these facilities for different diagnostic and therapeutic procedure.

Newborn Screening Market: Geographical Overview

The newborn screening market in North America has experienced significant growth in recent years. The demand for newborn screening services has increased significantly with the surging awareness among parents and healthcare professionals about the importance of early screening for identifying and managing congenital disorders. Additionally, improvements in medical technology have been crucial in enhancing newborn screening capabilities-laboratory automation has boosted screening accuracy, speed, and cost-effectiveness. This has made it possible for medical professionals to give thorough newborn screening panels that cover a larger spectrum of genetic and metabolic disorders. Favorable legislation and regulatory measures also benefit the newborn screening market in North America. Many states and provinces have implemented mandatory newborn screening programs, ensuring all infants are screened shortly after birth. For instance, every state in the US offers newborn screening as a public health program; yearly, ~4 million babies are screened under this program for illnesses that aren't often present at the time of delivery. The Texas Department of Health and Human Services began screening newborns for Spinal Muscular Atrophy (SMA) in June 2021.

A few of the major primary and secondary sources referred to while preparing the report on the newborn screening market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization).

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the newborn screening market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global newborn screening market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the newborn screening market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Newborn Screening Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Global PEST Analysis

5. Newborn Screening Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Surging Government Funding for Newborn Screening
    • 5.1.2 Rising Burden of Congenital Diseases
    • 5.1.3 Increasing Prevalence of Newborn Disorders
  • 5.2 Key Market Restraints
    • 5.2.1 Lack of Uniformity in Newborn Screening Policies and Practices
  • 5.3 Key Market Opportunities
    • 5.3.1 Genetic Screening of Newborns
  • 5.4 Future Trends
    • 5.4.1 Integration of Machine Learning and Artificial Intelligence in Screening
  • 5.5 Impact Analysis:

6. Newborn Screening Market - Global Market Analysis

  • 6.1 Newborn Screening Market Revenue (US$ Mn), 2022 - 2030

7. Global Newborn Screening Market - Revenue and Forecast to 2030 - by Product Type

  • 7.1 Overview
  • 7.2 Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • 7.3 Reagents and Assay Kits
    • 7.3.1 Overview
    • 7.3.2 Reagents and Assay Kits: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 Global Newborn Screening Market, by Reagents and Assay Kits, 2020-2030 (US$ Million)
  • 7.4 Instruments
    • 7.4.1 Overview
    • 7.4.2 Instruments: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.4.2.1 Global Newborn Screening Market, by Instruments, 2020-2030 (US$ Million)

8. Global Newborn Screening Market - Revenue and Forecast to 2030 - by Technology

  • 8.1 Overview
  • 8.2 Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
  • 8.3 Tandem Mass Spectrometry (TMS)
    • 8.3.1 Overview
    • 8.3.2 Tandem Mass Spectrometry (TMS): Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Molecular Assays
    • 8.4.1 Overview
    • 8.4.2 Molecular Assays: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Immunoassays and Enzymatic Assays
    • 8.5.1 Overview
    • 8.5.2 Immunoassays and Enzymatic Assays: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Pulse Oximetry Screening Technology
    • 8.6.1 Overview
    • 8.6.2 Pulse Oximetry Screening Technology: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Other Technologies
    • 8.7.1 Overview
    • 8.7.2 Other Technologies: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Newborn Screening Market - Revenue and Forecast to 2030 - by Test Type

  • 9.1 Overview
  • 9.2 Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 9.3 Dry Blood Spot Test
    • 9.3.1 Overview
    • 9.3.2 Dry Blood Spot Test: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Hearing Screen Test
    • 9.4.1 Overview
    • 9.4.2 Hearing Screen Test: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Critical Congenital Heart Diseases (CCHD) Test
    • 9.5.1 Overview
    • 9.5.2 Critical Congenital Heart Diseases (CCHD) Test: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Other Test Types
    • 9.6.1 Overview
    • 9.6.2 Other Test Types: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

10. Global Newborn Screening Market - Revenue and Forecast to 2030 - by End User

  • 10.1 Overview
  • 10.2 Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
  • 10.3 Hospitals and Clinics
    • 10.3.1 Overview
    • 10.3.2 Hospitals and Clinics: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Diagnostic Laboratories
    • 10.4.1 Overview
    • 10.4.2 Diagnostic Laboratories: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

11. Newborn Screening Market - Geographical Analysis

  • 11.1 North America Newborn Screening Market, Revenue and Forecast To 2030
    • 11.1.1 Overview
    • 11.1.2 North America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.3 North America: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
      • 11.1.3.1 North America: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
      • 11.1.3.2 North America: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    • 11.1.4 North America: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    • 11.1.5 North America: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    • 11.1.6 North America: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.1.6.1 North America Newborn Screening Market, by Country
      • 11.1.6.2 US
        • 11.1.6.2.1 US Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.6.2.2 US: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.1.6.2.2.1 US: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.1.6.2.2.2 US: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.1.6.2.3 US: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.1.6.2.4 US: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.1.6.2.5 US: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.1.6.3 Canada
        • 11.1.6.3.1 Canada Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.6.3.2 Canada: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.1.6.3.2.1 Canada: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.1.6.3.2.2 Canada: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.1.6.3.3 Canada: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.1.6.3.4 Canada: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.1.6.3.5 Canada: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.1.6.4 Mexico
        • 11.1.6.4.1 Mexico Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.6.4.2 Mexico: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.1.6.4.2.1 Mexico: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.1.6.4.2.2 Mexico: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.1.6.4.3 Mexico: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.1.6.4.4 Mexico: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.1.6.4.5 Mexico: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  • 11.2 Europe Newborn Screening Market, Revenue and Forecast to 2030
    • 11.2.1 Overview
    • 11.2.2 Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.3 Europe: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
      • 11.2.3.1 Europe: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
      • 11.2.3.2 Europe: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    • 11.2.4 Europe: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    • 11.2.5 Europe: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    • 11.2.6 Europe: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.2.6.1 Europe Newborn Screening Market, by Country
      • 11.2.6.2 UK
        • 11.2.6.2.1 UK Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.2.2 UK: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.2.2.1 UK: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.2.2.2 UK: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.2.3 UK: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.2.6.2.4 UK: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.2.6.2.5 UK: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.2.6.3 Germany
        • 11.2.6.3.1 Germany Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.3.2 Germany: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.3.2.1 Germany: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.3.2.2 Germany: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.3.3 Germany: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.2.6.3.4 Germany: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.2.6.3.5 Germany: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.2.6.4 France
        • 11.2.6.4.1 France Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.4.2 France: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.4.2.1 France: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.4.2.2 France: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.4.3 France: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.2.6.4.4 France: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.2.6.4.5 France: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.2.6.5 Italy
        • 11.2.6.5.1 Italy Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.5.2 Italy: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.5.2.1 Italy: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.5.2.2 Italy: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.5.3 Italy: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.2.6.5.4 Italy: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.2.6.5.5 Italy: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.2.6.6 Spain
        • 11.2.6.6.1 Spain Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.6.2 Spain: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.6.2.1 Spain: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.6.2.2 Spain: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.6.3 Spain: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.2.6.6.4 Spain: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.2.6.6.5 Spain: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.2.6.7 Rest of Europe
        • 11.2.6.7.1 Rest of Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.7.2 Rest of Europe: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.7.2.1 Rest of Europe: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.7.2.2 Rest of Europe: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.2.6.7.3 Rest of Europe: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.2.6.7.4 Rest of Europe: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.2.6.7.5 Rest of Europe: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  • 11.3 Asia Pacific Newborn Screening Market, Revenue and Forecast to 2030
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.3 Asia Pacific: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
      • 11.3.3.1 Asia Pacific: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
      • 11.3.3.2 Asia Pacific: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    • 11.3.4 Asia Pacific: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    • 11.3.5 Asia Pacific: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    • 11.3.6 Asia Pacific: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.3.6.1 Asia Pacific Newborn Screening Market, by Country
      • 11.3.6.2 China
        • 11.3.6.2.1 China Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.2.2 China: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.2.2.1 China: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.2.2.2 China: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.2.3 China: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.3.6.2.4 China: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.3.6.2.5 China: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.3.6.3 Japan
        • 11.3.6.3.1 Japan Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.3.2 Japan: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.3.2.1 Japan: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.3.2.2 Japan: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.3.3 Japan: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.3.6.3.4 Japan: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.3.6.3.5 Japan: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.3.6.4 India
        • 11.3.6.4.1 India Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.4.2 India: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.4.2.1 India: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.4.2.2 India: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.4.3 India: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.3.6.4.4 India: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.3.6.4.5 India: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.3.6.5 Australia
        • 11.3.6.5.1 Australia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.5.2 Australia: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.5.2.1 Australia: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.5.2.2 Australia: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.5.3 Australia: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.3.6.5.4 Australia: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.3.6.5.5 Australia: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.3.6.6 South Korea
        • 11.3.6.6.1 South Korea Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.6.2 South Korea: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.6.2.1 South Korea: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.6.2.2 South Korea: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.6.3 South Korea: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.3.6.6.4 South Korea: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.3.6.6.5 South Korea: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.3.6.7 Rest of Asia Pacific
        • 11.3.6.7.1 Rest of Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.7.2 Rest of Asia Pacific: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.7.2.1 Rest of Asia Pacific: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.7.2.2 Rest of Asia Pacific: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.3.6.7.3 Rest of Asia Pacific: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.3.6.7.4 Rest of Asia Pacific: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.3.6.7.5 Rest of Asia Pacific: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  • 11.4 Middle East & Africa Newborn Screening Market, Revenue and Forecast to 2030
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.4.3 Middle East & Africa: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
      • 11.4.3.1 Middle East & Africa: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
      • 11.4.3.2 Middle East & Africa: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    • 11.4.4 Middle East & Africa: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    • 11.4.5 Middle East & Africa: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    • 11.4.6 Middle East & Africa: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.4.6.1 Middle East & Africa Newborn Screening Market, by Country
      • 11.4.6.2 Saudi Arabia
        • 11.4.6.2.1 Saudi Arabia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.6.2.2 Saudi Arabia: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.4.6.2.2.1 Saudi Arabia: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.4.6.2.2.2 Saudi Arabia: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.4.6.2.3 Saudi Arabia: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.4.6.2.4 Saudi Arabia: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.4.6.2.5 Saudi Arabia: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.4.6.3 UAE
        • 11.4.6.3.1 UAE Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.6.3.2 UAE: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.4.6.3.2.1 UAE: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.4.6.3.2.2 UAE: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.4.6.3.3 UAE: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.4.6.3.4 UAE: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.4.6.3.5 UAE: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.4.6.4 South Africa
        • 11.4.6.4.1 South Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.6.4.2 South Africa: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.4.6.4.2.1 South Africa: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.4.6.4.2.2 South Africa: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.4.6.4.3 South Africa: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.4.6.4.4 South Africa: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.4.6.4.5 South Africa: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.4.6.5 Rest of Middle East & Africa
        • 11.4.6.5.1 Rest of Middle East & Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.6.5.2 Rest of Middle East & Africa: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.4.6.5.2.1 Rest of Middle East & Africa: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.4.6.5.2.2 Rest of Middle East & Africa: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.4.6.5.3 Rest of Middle East & Africa: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.4.6.5.4 Rest of Middle East & Africa: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.4.6.5.5 Rest of Middle East & Africa: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  • 11.5 South & Central America Newborn Screening Market, Revenue and Forecast to 2030
    • 11.5.1 Overview
    • 11.5.2 South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.5.3 South & Central America: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
      • 11.5.3.1 South & Central America: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
      • 11.5.3.2 South & Central America: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    • 11.5.4 South & Central America: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    • 11.5.5 South & Central America: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    • 11.5.6 South & Central America: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.5.6.1 South & Central America Newborn Screening Market, by Country
      • 11.5.6.2 Brazil
        • 11.5.6.2.1 Brazil Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.6.2.2 Brazil: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.5.6.2.2.1 Brazil: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.5.6.2.2.2 Brazil: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.5.6.2.3 Brazil: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.5.6.2.4 Brazil: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.5.6.2.5 Brazil: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.5.6.3 Argentina
        • 11.5.6.3.1 Argentina Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.6.3.2 Argentina: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.5.6.3.2.1 Argentina: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.5.6.3.2.2 Argentina: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.5.6.3.3 Argentina: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.5.6.3.4 Argentina: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.5.6.3.5 Argentina: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.5.6.4 Rest of South & Central America
        • 11.5.6.4.1 Rest of South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.6.4.2 Rest of South & Central America: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 11.5.6.4.2.1 Rest of South & Central America: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 11.5.6.4.2.2 Rest of South & Central America: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 11.5.6.4.3 Rest of South & Central America: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.5.6.4.4 Rest of South & Central America: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 11.5.6.4.5 Rest of South & Central America: Newborn Screening Market, by End User, 2020-2030 (US$ Million)

12. Newborn Screening Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Newborn Screening Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 LifeCell International Pvt Ltd
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Zentech SA
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Trivitron Healthcare Pvt Ltd
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 PerkinElmer Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Waters Corp
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Bio-Rad Laboratories Inc
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Masimo Corp
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Natus Medical Inc.
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Baebies Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 MRC Holland BV
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Medtronic Plc
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Newborn Screening Market Segmentation
  • Table 2. Global Newborn Screening Market, by Reagents and Assay Kits - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Global Newborn Screening Market, by Instruments - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. North America Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. North America Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. North America Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. North America Newborn Screening Market, by Test Type- Revenue and Forecast to 2030 (US$ Million)
  • Table 9. North America Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. US Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. US Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. US Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. US Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. US Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. US Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Canada Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Canada Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Canada Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Canada Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Canada Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Canada Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Mexico Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Mexico Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Mexico Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Mexico Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Mexico Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Mexico Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. Europe Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. Europe Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. Europe Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. Europe Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Europe Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Europe Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. UK Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. UK Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. UK Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. UK Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. UK Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. UK Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. Germany Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 41. Germany Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 42. Germany Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 43. Germany Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 44. Germany Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 45. Germany Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 46. France Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 47. France Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 48. France Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 49. France Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 50. France Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 51. France Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 52. Italy Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 53. Italy Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 54. Italy Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 55. Italy Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 56. Italy Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 57. Italy Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 58. Spain Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 59. Spain Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 60. Spain Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 61. Spain Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 62. Spain Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 63. Spain Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 64. Rest of Europe Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 65. Rest of Europe Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 66. Rest of Europe Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 67. Rest of Europe Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 68. Rest of Europe Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 69. Rest of Europe Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 70. Asia Pacific Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 71. Asia Pacific Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 72. Asia Pacific Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 73. Asia Pacific Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 74. Asia Pacific Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 75. Asia Pacific Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 76. China Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 77. China Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 78. China Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 79. China Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 80. China Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 81. China Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 82. Japan Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 83. Japan Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 84. Japan Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 85. Japan Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 86. Japan Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 87. Japan Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 88. India Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 89. India Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 90. India Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 91. India Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 92. India Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 93. India Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 94. Australia Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 95. Australia Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 96. Australia Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 97. Australia Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 98. Australia Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 99. Australia Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 100. South Korea Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 101. South Korea Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 102. South Korea Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 | (US$ Million)
  • Table 103. South Korea Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 104. South Korea Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 105. South Korea Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 106. Rest of Asia Pacific Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 107. Rest of Asia Pacific Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 108. Rest of Asia Pacific Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 109. Rest of Asia Pacific Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 110. Rest of Asia Pacific Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 111. Rest of Asia Pacific Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 112. Middle East & Africa Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 113. Middle East & Africa Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 114. Middle East & Africa Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 115. Middle East & Africa Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 116. Middle East & Africa Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 117. Middle East & Africa Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 118. Saudi Arabia Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 119. Saudi Arabia Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 120. Saudi Arabia Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 121. Saudi Arabia Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 122. Saudi Arabia Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 123. Saudi Arabia Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 124. UAE Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 125. UAE Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 126. UAE Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 127. UAE Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 128. UAE Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 129. UAE Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 130. South Africa Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 131. South Africa Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 132. South Africa Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 133. South Africa Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 134. South Africa Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 135. South Africa Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 136. Rest of Middle East & Africa Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 137. Rest of Middle East & Africa Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 138. Rest of Middle East & Africa Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 139. Rest of Middle East & Africa Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 140. Rest of Middle East & Africa Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 141. Rest of Middle East & Africa Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 142. South & Central America Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 143. South & Central America Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 144. South & Central America Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 145. South & Central America Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 146. South & Central America Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 147. South & Central America Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 148. Brazil Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 149. Brazil Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 150. Brazil Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 151. Brazil Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 152. Brazil Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 153. Brazil Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 154. Argentina Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 155. Argentina Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 156. Argentina Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 157. Argentina Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 158. Argentina Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 159. Argentina Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 160. Rest of South & Central America Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 161. Rest of South & Central America Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 162. Rest of South & Central America Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 163. Rest of South & Central America Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 164. Rest of South & Central America Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 165. Rest of South & Central America Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 166. Recent Organic Growth Strategies in Newborn Screening Market
  • Table 167. Recent Inorganic Growth Strategies in the Newborn Screening Market
  • Table 168. Glossary of Terms, Newborn Screening Market

List Of Figures

  • Figure 1. Newborn Screening Market Segmentation, By Geography
  • Figure 2. Global - PEST Analysis
  • Figure 3. Newborn Screening Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Newborn Screening Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Newborn Screening Market Revenue, Geography (US$ Mn), 2022 - 2030
  • Figure 7. Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • Figure 8. Reagents and Assay Kits: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Instruments: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 11. Tandem Mass Spectrometry (TMS): Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Molecular Assays: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Immunoassays and Enzymatic Assays: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Pulse Oximetry Screening Technology: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Other Technologies: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 17. Dry Blood Spot Test: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Hearing Screen Test: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Critical Congenital Heart Diseases (CCHD) Test: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Other Test Types: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
  • Figure 22. Hospitals and Clinics: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Diagnostic Laboratories: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. North America: Newborn Screening Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 25. North America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. North America Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
  • Figure 27. US Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Canada Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Mexico Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Europe Newborn Screening Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 31. Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Europe Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
  • Figure 33. UK Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Germany Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 35. France Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. Italy Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 37. Spain Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 38. Rest of Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 39. Asia Pacific Newborn Screening Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 40. Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 41. Asia Pacific Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
  • Figure 42. China Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 43. Japan Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 44. India Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 45. Australia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 46. South Korea Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 47. Rest of Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 48. Middle East & Africa Newborn Screening Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 49. Middle East & Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 50. Middle East & Africa Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
  • Figure 51. Saudi Arabia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 52. UAE Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 53. South Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 54. Rest of Middle East & Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 55. South & Central America Newborn Screening Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 56. South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 57. South & Central America Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
  • Figure 58. Brazil Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 59. Argentina Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 60. Rest of South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 61. Growth Strategies in Newborn Screening Market